Nitrostat
Product Images NDC 21695-450

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nitrostat (NDC 21695-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dcb552c1 310a 48af 81ad A74530531dee 01)

FDA Label Image

Logo (Dcb552c1 310a 48af 81ad A74530531dee 02)

This is a distribution information indicating that Parke-Davis, a division of Player, is located in New York at zip code 10017.*

FDA Label Image

Logo (Dcb552c1 310a 48af 81ad A74530531dee 03)

This text only contains a company name and an address, which tells us that it is distributed by Parke-Davis, a division of Plaer located in New York City. However, it does not provide any further context or information.*

FDA Label Image

Nitrostat 0.4mg (1/150gr) (Dcb552c1 310a 48af 81ad A74530531dee 04)

Nitrostat 0.4mg is a medication that comes in sublingual tablet form. Each tablet contains 0.4mg of nitroglycerin. The product is identified with the ID RN045000 and distributed by Pfizer Pharmaceuticals in Vega Baja, PR 00694. The medication should be stored at a controlled room temperature between 15°C-30°C (59°F-86°F) and kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.